Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Natalizumab versus fingolimod in patients with relapsing-remitting multiple sclerosis non-responding to first-line injectable therapies.
Barriers experienced by patients with multiple sclerosis in seeking care for lower urinary tract symptoms.
Evaluation of pulsing magnetic field effects on paresthesia in multiple sclerosis patients, a randomized, double-blind, parallel-group clinical trial.
Thalamocortical-auditory network alterations following cuprizone-induced demyelination.
Drug-associated progressive multifocal leukoencephalopathy: a clinical, radiological, and cerebrospinal fluid analysis of 326 cases.
Increased incidence of rheumatoid arthritis in multiple sclerosis: A nationwide cohort study.
Motor Skill Acquisition Promotes Human Brain Myelin Plasticity.
Acute ganglion cell loss during rapid visual recovery in optic neuritis.
Population PK-PD Analyses of CD25 Occupancy, CD56(bright) NK Cell Expansion, and Regulatory T Cell Reduction by Daclizumab HYP in Subjects with Multiple Sclerosis.
Longitudinally extensive transverse myelitis: A retrospective analysis of sixty-four patients at tertiary care center of North-West India.
Obeticholic acid, a synthetic bile acid agonist of the farnesoid X receptor, attenuates experimental autoimmune encephalomyelitis.
Assessing and treating pain associated with stroke, multiple sclerosis, cerebral palsy, spinal cord injury and spasticity. Evidence and recommendations from the Italian Consensus conference on Pain in Neurorehabilitation.
Proof of Principle: Coronin 1A - An Intrinsic Modulator of T Lymphocyte Function.
The Dress: Transforming a web viral event into a scientific survey.
Cryptococcal meningitis after fingolimod discontinuation in a patient with multiple sclerosis.
Donepezil promotes differentiation of neural stem cells into mature oligodendrocytes at the expense of astrogenesis.
Glial and neuronal markers in cerebrospinal fluid in different types of multiple sclerosis.
Benefit-Risk of Therapies for Relapsing-Remitting Multiple Sclerosis: Testing the Number Needed to Treat to Benefit (NNTB), Number Needed to Treat to Harm (NNTH) and the Likelihood to be Helped or Harmed (LHH): A Systematic Review and Meta-Analysis.
Adverse working events in patients with multiple sclerosis.
Tiam1/Rac1 complex controls Il17a transcription and autoimmunity.
Deficits in medio-lateral balance control and the implications for falls in individuals with multiple sclerosis.
IL-27: a potential biomarker for responders to glatiramer acetate therapy.
Fatigue and depression in multiple sclerosis: pharmacological and non-pharmacological interventions.
Adipose-Derived Cells (Stromal Vascular Fraction) Transplanted for Orthopedical or Neurological Purposes: Are They Safe Enough?
Parkinson's disease and the Stroop color word test: processing speed and interference algorithms.
Pages
« first
‹ previous
…
804
805
806
807
808
809
810
811
812
…
next ›
last »